Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-04-27 to 2022-05-18
Current total value of award: $25547.76
Description: 4557301671!TYSABRI 300 MG/15 ML VIAL 15ML